20 March 2024

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors

15 December 2022

Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer

29 August 2022

Selected Scientific Publications based on our PQR620 compound

29 August 2022

Selected Scientific Publications based on our PQR309 compound